Compare Inovio Pharmaceuticals Inc (INO) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Keysight Technologies Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Keysight Technologies Inc trades at $346.15 (market cap $58.74B). The key difference: Keysight Technologies Inc is far larger — about 747.8× Inovio Pharmaceuticals Inc's market cap, and Keysight Technologies Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | KEYS | |
|---|---|---|
Market Cap | $78.55M | $58.74B |
Sector | Health | Technology |
52-Week High | $2.87 | $373.34 |
52-Week Low | $0.66 | $158.51 |
Enterprise Value | $49.56M | $59.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
